How do health care professionals respond to advice on adverse side effects of contraceptive methods? The case of Depo Provera®

Contraception

Volumn 76, Issue 1, 2007, Pages 18-22

  Glasier, Anna ^a   Yan, Yan ^a   Wellings, Kaye ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Adolescents; Attitudes; Bone density; Depo Provera; Health scares; Practitioners

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADULT; ADVERSE OUTCOME; ARTICLE; CONTRACEPTION; CONTROLLED STUDY; FEMALE; HEALTH CARE PERSONNEL; HEALTH PERSONNEL ATTITUDE; HUMAN; HUMAN EXPERIMENT; IMPLANT; MALE; MEDICAL PRACTICE; NURSE; OSTEOPOROSIS; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; SELF REPORT; STRUCTURED QUESTIONNAIRE; TREATMENT DURATION; UNITED KINGDOM;

AGE FACTORS; BONE DENSITY; CONTRACEPTIVE AGENTS, FEMALE; EVIDENCE-BASED MEDICINE; FEMALE; GREAT BRITAIN; HEALTH CARE SURVEYS; HUMANS; MALE; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; PRODUCT SURVEILLANCE, POSTMARKETING; QUESTIONNAIRES;

EID: 34250630121     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.03.013     Document Type: Article

References (29)

1. Shickle D. On a supposed right to lie [to the public] from benevolent motives: communicating health risks to the public. Med Health Care Philos 3 (2000) 241-249
2. Furedi A. The public health implications of the 1995 'pill scare'. Hum Reprod Update 5 (1999) 621-626
3. Wood R., Botting B., and Dunnell K. Trends in conceptions before and after the 1995 pill scare. Popul Trends 89 (1997) 5-12
4. Bromham D.R. Another pill scare - should we audit its impact?. Audit Unit News 1 (1996) 2-3
5. Flett G., Gurney E., McKessock L., and Reid J. Impact of the October 1995 pill scare in Grampian. Br J Fam Plann 24 (1998) 18-20
6. de Vries C.S., van den Berg P.B., and de Jong-van den Berg L.T. Oral contraceptive use before and after the latest pill scare in The Netherlands. Changes in oral contraceptive use and how users change. Contraception 57 (1998) 247-249
7. Skjeldestad F.E. Increased number of induced abortions in Norway after media coverage of adverse vascular events from the use of third-generation oral contraceptives. Contraception 55 (1997) 11-14
8. Taylor T., Keyse L., and Bryant A. Contraception and sexual health 2005/06. A report on research using the ONS Omnibus Survey produced by the Office for National Statistics on behalf of the Department of Health, London (2006), Office for National Statistics, London
9. Scholes D., LaCroix A.Z., Ichikawa L.E., Barlow W.E., and Ott S.M. Injectable hormone contraception and bone density: results from a prospective study. Epidemiology 13 (2002) 581-587
10. Berenson A.B., Radecki C.M., Grady J.J., Rickert V.I., and Thomas A. Effects of hormonal contraception on bone mineral density after 24 months of use. Obstet Gynecol 103 (2004) 899-906
11. Petitti D.B., Piaggio G., Mehta S., Cravioto M.C., Meirik O., and for the WHO study of hormonal contraception and bone health. Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. Obstet Gynecol 95 (2000) 736-744
12. Updated prescribing advice on the effect of Depo-Provera contraception on bones. MHRAPublicHealthLinkDepo-Provera 16Nov2004 [Accessed November 29, 2006]
13. Busen N.H., Britt R.B., and Rianon N. Bone mineral density in a cohort of adolescent women using depot medroxyprogesterone acetate for one to two years. J Adolesc Health 32 (2003) 257-259
14. Kaunitz A.M. Long-acting hormonal contraceptives - indispensable in preventing pregnancy. J Adolesc Health 97 (2007) 1-3
15. Teenage pregnancy. Social Exclusion Unit. London; 1999. Available at:. http://www.dfes.gov.uk/teenagepregnancy/dsp_content.cfm?pageID=84 [Accessed May 3, 2007]
16. Scottish Executive. Respect & responsibility - strategy and action plan for improving sexual health. Edinburgh, 2005. Available at:. http://www.scotland.gov.uk/Publications/2005/01/20603/51174 [Accessed May 3, 2007]
17. Santelli J.S., Lindberg L.D., Finer L.B., and Singh S. Explaining recent declines in adolescent pregnancy in the United States: the contribution of abstinence and improved contraceptive use. Am J Public Health 97 (2007) 1-7
18. National Institute for Health and Clinical Excellence long-acting reversible contraception. www.nice.org.uk Accessed 11/25/06
19. Westhoff C. Contraceptive adherence and continuation rates. In: Glasier A., Wellings K., and Critchley H. (Eds). Contraception and contraceptive use (2005), RCOG Press, London (UK) 108-118
20. Darney P.D., Callegari L.S., Swift A., Atkinson E.S., and Robert A.M. Condom practices of urban teens using Norplant contraceptive implants, oral contraceptives and condoms for contraception. Am J Obstet Gynecol 180 (1998) 929-937
21. Stevens-Simon C., Kelly L., and Kulick R. A village would be nice but... ...it takes a long-acting contraceptive to prevent repeat adolescent pregnancies. Am J Prev Med 21 (2001) 60-65
22. Rickert V.I., Tiezzi L., Lipschutz J., Leon J., Vaughan R.D., and Westhoff C. Depo now: preventing unintended pregnancies among adolescents and young adults. J Adolescent Health 97 (2007) 22-28
23. Wellings K. Zhihing Z. Barrett G. Krentel A. Glasier A. Attitudes towards long acting methods of contraception in general practice in the UK. Contraception [submitted].
24. World Health Organisation. Technical consultation on the effect ofhormonal contraception on bone health. Summary Report 2006. http://www.who.int/reproductive-health/family_planning/docs/hc_bonehealth/consultation_rpt.pdf [Accessed March 9, 2007].
25. Grady W.R., Bill J.O.G., and Klepinger D.H. Contraceptive method switching in the United States. Perspect Sex Reprod Health 34 (2002) 135-145
26. Lakha F., and Glasier A. Continuation rates of Implanon in the UK: data from an observational study in a clinical setting. Contraception 74 (2006) 287-289
27. Little P., Griffin S., Kelly J., Dickson N., and Sadler C. Effect of educational leaflets and questions on knowledge of contraception in women taking the combined contraceptive pill: randomised controlled trial. BMJ 316 (1998) 1948-1952
28. Berry D.C., Raynor D.K., Knapp P., and Bersellini E. Official warnings on thromboembolism risk with oral contraceptives fail to inform users adequately. Contraception 66 (2002) 305-307
29. Smith L.F., and Whitfield M.J. Women's knowledge of taking oral contraceptive pills correctly and of emergency contraception: effect of providing information leaflets in general practice. Br J Gen Pract 45 (1995) 409-414